http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107260719-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a92e577605453de29657784f4b1bd76
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
filingDate 2017-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18892265ca1526cf26213894bae2d7eb
publicationDate 2017-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107260719-A
titleOfInvention Preparation method of anti-hepatitis drug piperidopyrido 1,2-diazetidine-zinc complex
abstract The invention discloses a preparation method of an anti-hepatitis drug piperidopyrido-1,2-diazetidine-zinc complex, which belongs to the technical field of pharmaceutical chemical synthesis. Technical solution main points of the present invention are: Compared with the prior art, the present invention has the following beneficial effects: the synthetic method of the present invention is simple, the molecular structure is novel and the obtained compound Injection has significant preventive or therapeutic effect on acute and chronic liver injury caused by carbon tetrachloride and D-galactosamine, the dose and intensity of the effect are equivalent or similar to tiopronin, and it is expected to be further popularized and applied.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110185713-A
priorityDate 2017-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409311332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467941357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466740230
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID147886772
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465925385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164091197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466356150
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425115205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146777134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148258979
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467378092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467602979
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410635597
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135397610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407059538

Total number of triples: 30.